Eli Lilly, an American pharmaceutical giant, is testing models for diabetes treatment in countries such as India, South Africa and Brazil (it also provides free insulin to AMPATH in Kenya).

ECONOMIST: Chronic diseases in developing countries

Twenty of the 23 patients who received the treatment became insulin-free - one for as long as four years.

BBC: Stem cells 'can treat diabetes'